Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Panthera issues update on Bhukia dispute, secures litigation funding

(Sharecast News) - Gold explorer and developer Panthera Resources updated the market on the ongoing dispute with the Republic of India over the Bhukia project on Wednesday, confirming that it had secured litigation financing for the dispute.

The AIM-traded firm said the dispute centred on India's alleged breaches of obligations under the 1999 agreement between the governments of Australia and India on the promotion and protection of investments.

It said the government of Rajasthan (GoR) recently announced the preferred bidder for the Bhukia-Jagpura block, which includes the Bhukia project, with a 'highest final price offer' of 65.3%.

That percentage refers to the value of minerals dispatched each month, multiplied by the sale price of the mineral as published by the Indian Bureau of Mines.

The Geological Survey of India (GSI) reported a mineral resource of 7.15 million ounces of gold in the Bhukia project, valued at about $16.7bn based on recent gold prices.

For the preferred bidder to qualify for the mining lease, they would need to make an upfront payment and provide a performance security, each amounting to around $60m.

Panthera said it believed the mineral resource potential of Bhukia exceeded the GSI's reported estimates, based on earlier work and subsequent evaluations.

Its subsidiary Indo Gold (IGPL) holds legal rights to the Bhukia area through Metal Mining (MMI), which had its prospecting licence application rejected by the GoR in August 2018.

Despite IGPL's substantial investment and management of exploration programmes since 2005, the GoR had consistently frustrated IGPL's right to a prospecting licence, citing various legally untenable grounds, Panthera explained.

It said India's new Mines and Minerals Development and Regulation Act of 2021 (MMDR2021) had further complicated the issue by lapsing preferential rights to prospecting licences and mining leases, though it included provisions for reimbursement of expenditures.

IGPL was arguing that under the treaty, it was entitled to fair and equitable compensation, not merely reimbursement.

The company said the acts and omissions by the GoR and India, including the MMDR2021 enactment and the rejection of MMI's writ petition, constituted breaches of the treaty, particularly articles three, four and seven, which cover the promotion and protection of investments, the treatment of investments, and expropriation and nationalisation.

IGPL was planning to seek damages from India, although the outcome of the treaty claims remained uncertain.

Panthera said its exploration at Bhukia revealed significant gold resources, with early estimates indicating 1.74 million ounces.

The GSI's 2014 report and subsequent updates suggested even larger resources, reinforcing Bhukia's potential for a large, low-cost, open-pit gold mining operation.

To support its legal efforts, IGPL had secured up to $13.6m in litigation financing from LCM Funding SG, a subsidiary of Litigation Capital Management.

The non-recourse facility would fund IGPL's prosecution of its treaty claims against India, with repayment contingent on achieving an award or recovery.

At 1238 BST, shares in Panthera Resources were up 27.98% at 7.17p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Ethernity secures $1.05m licence agreement
(Sharecast News) - Data processing semiconductor technology specialist Ethernity Networks announced on Friday that it had secured a $1.05m licence agreement with a new tier one US-based aerospace system products provider.
Mirriad flags weaker first-half revenue
(Sharecast News) - Virtual product placement and in-content advertising specialist Mirriad said in an update on Friday that it expected revenue for the first half to be around £0.4m, down from £0.59m in the first six months of the 2023 financial year.
European drugs body backs Moderna jab
(Sharecast News) - Europe's drug regulator has backed Moderna's novel vaccine for respiratory syncytial virus, the US pharmaceutical firm announced on Friday.
Symphony reports consistent trading as it works to accelerate projects
(Sharecast News) - Symphony Environmental Technologies said in an update on Friday that its trading remained consistent with recent statements.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.